The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

General Cancer Screen 37 Tissue Microarray - LS-SCA37

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SCA37
Product Name:	General Cancer Screen 37
Description:	Various organ tumors with stage/grade
Format:	FFPE
Category:	Human Multi-Tumor
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1 mm
Core Thickness:	5 µm
Cases:	208
Cores:	209
Slides Per Set:	1

LS-SCA37 Tissue Microarray Map

Slide Number 1

LABEL

Sto

Eso

Col

Liv

Pnc

Liv

Pnc

Lng

Brn

Spl

Tyd

Lym

Chk

Gin

Skn

Pls

Nos

Skn

Adi

Skn

Rec

Bst

Ova

Ute

Cvx

Pst

Tes

Kid

Bla

Skn

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Adipose, Thigh (Adi); Bladder (Bla); Brain, Cerebrum (Brn); Breast (Bst); Cervix (Cvx); Cheek (Chk); Colon (Col); Esophagus (Eso); Gingiva (Gin); Kidney (Kid); Liver (Liv); Lung (Lng); Lymph node (Lym); Lymph node, Groin (Lym); Lymph node, Neck (Lym); Nose (Nos); Ovary (Ova); Palate, Soft (Pls); Pancreas (Pnc); Prostate (Pst); Rectum (Rec); Skin (Skn); Skin, Abdomen (Skn); Skin, Arm, Fibrous tissue and blood vessel (Skn); Skin, Buttock (Skn); Skin, Chest wall (Skn); Skin, Face (Skn); Skin, Foot (Skn); Skin, Foot dorsum (Skn); Skin, Foot sole (Skn); Skin, Head (Skn); Skin, Lip (Skn); Skin, Thigh (Skn); Skin, Waist and Back (Skn); Spleen (Spl); Stomach (Sto); Testis (Tes); Thyroid (Tyd); Uterus (Ute);

LS-SCA37 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade	Tumor Stage	Tumor Differentiation	Gleason Score
1	A1	Human	M	59 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	1	II
1	A2	Human	M	56 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A3	Human	M	60 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A4	Human	M	61 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	1	IB
1	A5	Human	F	66 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	3	II
1	A6	Human	M	60 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	A7	Human	M	65 y	Stomach (Sto)	Adenocarcinoma	Malignant	T4N0M0	3	IIIA
1	A8	Human	M	40 y	Stomach (Sto)	Adenocarcinoma	Malignant	T4N0M0	3	IIIA
1	A9	Human	M	71 y	Esophagus (Eso)	Adenocarcinoma	Malignant	T4N0M0	1	III
1	A10	Human	M	70 y	Esophagus (Eso)	Adenocarcinoma	Malignant	T2N0M0	2	IIA
1	A11	Human	M	63 y	Esophagus (Eso)	Adenocarcinoma	Malignant	T3N0M0	3	IIA
1	A12	Human	M	53 y	Esophagus (Eso)	Adenocarcinoma	Malignant	T3N0M0	3	IIA
1	A13	Human	M	58 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T2N0M0	1	IIA
1	A14	Human	M	52 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T3N0M0	2	IIA
1	A15	Human	M	46 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T3N0M0	2	IIA
1	A16	Human	F	65 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T3N0M0	3	IIA
1	B1	Human	M	59 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	1	II
1	B2	Human	M	46 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	2	II
1	B3	Human	F	58 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	2	II
1	B4	Human	F	79 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	2-3	II
1	B5	Human	M	66 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	1	II
1	B6	Human	M	56 y	Colon (Col)	Adenocarcinoma	Malignant	T2N0M0	2	II
1	B7	Human	M	53 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	2	II
1	B8	Human	M	46 y	Colon (Col)	Adenocarcinoma	Malignant	T4N0M0	3	II
1	B9	Human	M	46 y	Liver (Liv)	Hepatocellular carcinoma with necrosis	Malignant	T2N0M0	2	II
1	B10	Human	M	33 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	B11	Human	F	67 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T1N0M0	1	I
1	B12	Human	F	35 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	B13	Human	M	19 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	B14	Human	M	47 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	3	II
1	B15	Human	M	75 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	3	II
1	B16	Human	M	37 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	C1	Human	M	50 y	Pancreas (Pnc)	Ductal adenocarcinoma	Malignant	T2N1M0	2	III
1	C2	Human	F	53 y	Pancreas (Pnc)	Ductal adenocarcinoma with necrosis	Malignant	T3N0M0	2	II
1	C3	Human	M	55 y	Pancreas (Pnc)	Ductal adenocarcinoma	Malignant	T3N0M0	2	II
1	C4	Human	M	44 y	Pancreas (Pnc)	Ductal adenocarcinoma	Malignant	T3N0M0	2	II
1	C5	Human	F	76 y	Liver (Liv)	Ductal adenocarcinoma	Malignant	T4N0M0		III
1	C6	Human	M	41 y	Pancreas (Pnc)	Ductal adenocarcinoma	Malignant	T4N1M0	2	III
1	C7	Human	F	54 y	Pancreas (Pnc)	Ductal adenocarcinoma	Malignant	T2N0M0	2	I
1	C8	Human	F	57 y	Pancreas (Pnc)	Ductal adenocarcinoma	Malignant	T2N0M0	2-3	I
1	C9	Human	M	44 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	II
1	C10	Human	M	68 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T2N0M0	2	I
1	C11	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	2	IIIA
1	C12	Human	M	69 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	C13	Human	F	42 y	Lung (Lng)	Adenocarcinoma	Malignant	T3N1M0	2	IIIA
1	C14	Human	M	70 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	2	I
1	C15	Human	M	51 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	3	I
1	C16	Human	M	49 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	3	I
1	D1	Human	F	65 y	Lung (Lng)	Large cell carcinoma	Malignant	T2N1M0		II
1	D2	Human	M	62 y	Lung (Lng)	Large cell carcinoma	Malignant	T3N0M0		III
1	D3	Human	M	60 y	Lung (Lng)	Large cell carcinoma	Malignant	T2N1M0		II
1	D4	Human	M	60 y	Lung (Lng)	Large cell carcinoma	Malignant	T2N0M0		I
1	D5	Human	M	73 y	Lung (Lng)	Small cell carcinoma with necrosis	Malignant	T3N1M0		IIIA
1	D6	Human	F	66 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N1M0		II
1	D7	Human	M	54 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N1M0		II
1	D8	Human	M	50 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N0M0		I
1	D9	Human	F	36 y	Brain, Cerebrum (Brn)	Astrocytoma	Tumor
1	D10	Human	M	35 y	Brain, Cerebrum (Brn)	Astrocytoma	Tumor		2
1	D11	Human	F	48 y	Brain, Cerebrum (Brn)	Astrocytoma	Tumor		2
1	D12	Human	F	36 y	Brain, Cerebrum (Brn)	Astrocytoma	Tumor		2-3
1	D13	Human	F	31 y	Brain, Cerebrum (Brn)	Glioblastoma	Malignant		4
1	D14	Human	F	52 y	Brain, Cerebrum (Brn)	Glioblastoma	Malignant		4
1	D15	Human	F	41 y	Brain, Cerebrum (Brn)	Glioblastoma	Malignant		4
1	D16	Human	F	6 y	Brain, Cerebrum (Brn)	Glioblastoma	Malignant		4
1	E1	Human	F	43 y	Spleen (Spl)	Diffuse B-cell lymphoma	Malignant
1	E2	Human	M	47 y	Spleen (Spl)	B cell lymphoma	Malignant
1	E3	Human	M	46 y	Spleen (Spl)	B cell lymphoma	Malignant
1	E4	Human	M	40 y	Spleen (Spl)	Diffuse B-cell lymphoma	Malignant
1	E5	Human	M	21 y	Spleen (Spl)	Diffuse B-cell lymphoma	Malignant
1	E6	Human	F	60 y	Spleen (Spl)	Diffuse plasmacytoid B-cell lymphoma	Malignant
1	E7	Human	M	38 y	Spleen (Spl)	Diffuse B-cell lymphoma	Malignant
1	E8	Human	M	18 y	Spleen (Spl)	Diffuse B-cell lymphoma	Malignant
1	E9	Human	F	36 y	Thyroid (Tyd)	Papillary carcinoma	Malignant	T3N0M0		I
1	E10	Human	F	60 y	Thyroid (Tyd)	Papillary carcinoma	Malignant	T2N0M0		II
1	E11	Human	F	70 y	Thyroid (Tyd)	Papillary carcinoma	Malignant	T2N0M0		II
1	E12	Human	F	65 y	Thyroid (Tyd)	Papillary carcinoma	Malignant	T2N0M0		II
1	E13	Human	M	63 y	Thyroid (Tyd)	Follicular carcinoma	Malignant	T3N0M0	3	II
1	E14	Human	F	36 y	Thyroid (Tyd)	Follicular carcinoma	Malignant	T3N0M0	2	I
1	E15	Human	F	43 y	Thyroid (Tyd)	Follicular carcinoma	Malignant	T2N0M0	2	I
1	E16	Human	F	29 y	Thyroid (Tyd)	Follicular carcinoma	Malignant	T1N0M0	3	I
1	F1	Human	M	17 y	Lymph node, Neck (Lym)	Hodgkin's lymphoma, Mixed	Malignant
1	F2	Human	F	73 y	Lymph node, Neck (Lym)	Hodgkin's lymphoma, Mixed	Malignant
1	F3	Human	F	31 y	Lymph node (Lym)	Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL)	Malignant
1	F4	Human	M	32 y	Lymph node, Neck (Lym)	Hodgkin's lymphoma, Mixed	Malignant
1	F5	Human	F	25 y	Lymph node, Neck (Lym)	T cell lymphoma	Malignant
1	F6	Human	F	68 y	Lymph node, Groin (Lym)	Follicular center cell lymphoma	Malignant
1	F7	Human	M	55 y	Lymph node (Lym)	T cell lymphoma	Malignant
1	F8	Human	F	76 y	Lymph node, Neck (Lym)	Anaplastic large cell lymphoma	Malignant
1	F9	Human	F	50 y	Cheek (Chk)	Squamous cell carcinoma	Malignant	T1N0M0		I
1	F10	Human	M	49 y	Gingiva (Gin)	Squamous cell carcinoma	Malignant	T4N0M0	1	IV
1	F11	Human	M	45 y	Skin, Head (Skn)	Squamous cell carcinoma with chronic inflammation	Malignant	T2N0M0		II
1	F12	Human	F	56 y	Palate, Soft (Pls)	Squamous cell carcinoma	Malignant	T2N0M0	2	II
1	F13	Human	F	63 y	Nose (Nos)	Squamous cell carcinoma	Malignant	T3N0M0	2	III
1	F14	Human	M	42 y	Nose (Nos)	Squamous cell carcinoma with granuloma	Malignant	T1N0M0	2-3	I
1	F15	Human	M	43 y	Nose (Nos)	Squamous cell carcinoma	Malignant	T3N0M0	2-3	III
1	F16	Human	M	56 y	Nose (Nos)	Squamous cell carcinoma	Malignant	T2N0M0	3	II
1	G1	Human	M	53 y	Skin, Lip (Skn)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	G2	Human	M	63 y	Skin (Skn)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	G3	Human	M	80 y	Skin, Face (Skn)	Squamous cell carcinoma	Malignant	T2N0M0	2	II
1	G4	Human	M	72 y	Skin, Buttock (Skn)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	G5	Human	M	60 y	Skin, Buttock (Skn)	Squamous cell carcinoma	Malignant	T3N0M0	1	II
1	G6	Human	M	68 y	Skin, Head (Skn)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	G7	Human	M	62 y	Skin, Head (Skn)	Squamous cell carcinoma	Malignant	T2N0M0	1	II
1	G8	Human	F	82 y	Skin, Face (Skn)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	G9	Human	M	32 y	Skin, Chest wall (Skn)	Dermatofibrosarcoma protuberans	Malignant	T2aN0M0		IB
1	G10	Human	M	15 y	Skin, Abdomen (Skn)	Dermatofibrosarcoma protuberans	Malignant	T2aN0M0		IB
1	G11	Human	M	58 y	Skin, Foot dorsum (Skn)	Dermatofibrosarcoma protuberans	Malignant	T2aN0M0		IB
1	G12	Human	F	58 y	Skin, Chest wall (Skn)	Dermatofibrosarcoma protuberans	Malignant	T1aN0M0		IA
1	G13	Human	M	72 y	Adipose, Thigh (Adi)	Leiomyosarcoma	Malignant	T1N0M0	Low	IA	Well
1	G14	Human	F	68 y	Skin, Waist and Back (Skn)	Liposarcoma, Myxoid	Malignant	T1N0M0	Intermediate	IIA
1	G15	Human	F	34 y	Skin, Thigh (Skn)	Liposarcoma, Myxoid	Malignant	T2N0M0	Intermediate	IIB
1	G16	Human	F	40 y	Skin, Thigh (Skn)	Liposarcoma, Myxoid	Malignant	T2N0M0	Intermediate	IIB
1	H1	Human	M	62 y	Skin, Foot (Skn)	Malignant melanoma	Malignant	T4N0M0		II
1	H2	Human	M	74 y	Skin, Foot (Skn)	Malignant melanoma	Malignant	T4N0M0		II
1	H3	Human	F	66 y	Skin, Chest wall (Skn)	Malignant melanoma with necrosis	Malignant	T4N0M0		II
1	H4	Human	M	61 y	Skin, Foot sole (Skn)	Malignant melanoma	Malignant	T4N0M0		II
1	H5	Human	M	52 y	Skin (Skn)	Malignant melanoma	Malignant	T3N0M0		II
1	H6	Human	F	47 y	Skin, Arm, Fibrous tissue and blood vessel (Skn)	Malignant melanoma	Malignant	T4N0M0		II
1	H7	Human	F	70 y	Rectum (Rec)	Malignant melanoma	Malignant
1	H8	Human	F	67 y	Rectum (Rec)	Malignant melanoma	Malignant
1	H9	Human	F	30 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T1cN0M0	1	I
1	H10	Human	F	54 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T1N0M0	2	I
1	H11	Human	F	50 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N1M0		IIIA
1	H12	Human	F	71 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N2M0	2	IIIA
1	H13	Human	F	37 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N0M0	2	IIA
1	H14	Human	F	63 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N0M0	2	IIA
1	H15	Human	F	65 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N0M0	2	II
1	H16	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T1N0M0	2	I
1	I1	Human	F	38 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T2N0M0		IIA
1	I2	Human	F	35 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T1N0M0		I
1	I3	Human	F	59 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T4N0M0		IIIB
1	I4	Human	F	69 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T2N0M0		IIA
1	I5	Human	F	51 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T2N1M0		IIB
1	I6	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T2N1M0		IIB
1	I7	Human	F	70 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T2N0M0		IIA
1	I8	Human	F	70 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	T2N2M0		IIIA
1	I9	Human	F	41 y	Ovary (Ova)	Adenocarcinoma	Malignant	T1aN0M0		IA
1	I10	Human	F	32 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1N0M0	1	I
1	I11	Human	F	73 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1bN0M0	2	IB
1	I12	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1cN0M0	2	IC
1	I13	Human	F	66 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3aN0M0	2	IIIA
1	I14	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1cN0M0	3	IC
1	I15	Human	F	55 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	3	IA
1	I16	Human	F	56 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	3	II
1	J1	Human	F	25 y	Ovary (Ova)	Dysgerminoma	Malignant	T1cN0M0		IC
1	J2	Human	F	8 y	Ovary (Ova)	Dysgerminoma	Malignant	T2bN0M0		IIB
1	J3	Human	F	36 y	Ovary (Ova)	Dysgerminoma	Malignant	T1bN0M0		IB
1	J4	Human	F	11 y	Ovary (Ova)	Dysgerminoma	Malignant	T1N0M0		I
1	J5	Human	F	46 y	Ovary (Ova)	Sertoli-stromal cell tumor	Tumor	T1aN0M0		IA	Moderately
1	J6	Human	F	40 y	Ovary (Ova)	Sertoli-stromal cell tumor	Tumor	T1N0M0		I	Moderately
1	J7	Human	F	59 y	Ovary (Ova)	Sertoli-stromal cell tumor	Tumor	T1N0M0		I	Moderately
1	J8	Human	F	26 y	Ovary (Ova)	Sertoli-stromal cell tumor	Tumor	T1N0M0		I	Poorly
1	J9	Human	F	40 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2N0M0	1	II
1	J10	Human	F	65 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1aN0M0	1	IA
1	J11	Human	F	53 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	1	IB
1	J12	Human	F	50 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2bN0M0	2	IIB
1	J13	Human	F	57 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2-3	IC
1	J14	Human	F	48 y	Uterus (Ute)	Adenocarcinoma	Malignant	T2N0M0	3	IIA
1	J15	Human	F	64 y	Uterus (Ute)	Adenocarcinoma	Malignant	T1bN0M0	3	IB
1	J16	Human	F	57 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	3	IC
1	K1	Human	F	62 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	K2	Human	F	49 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	K3	Human	F	55 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T2aN0M0	2	IIA
1	K4	Human	F	41 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	K5	Human	F	38 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1bN0M0	2	IB
1	K6	Human	F	49 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	K7	Human	F	37 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	K8	Human	F	29 y	Cervix (Cvx)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	K9	Human	M	70 y	Prostate (Pst)	Adenocarcinoma	Malignant	T3N0M0	2	III		3+4
1	K10	Human	M	73 y	Prostate (Pst)	Adenocarcinoma	Malignant	T2N0M0	1	II		3+4
1	K11	Human	M	73 y	Prostate (Pst)	Adenocarcinoma	Malignant	T2N0M0		II
1	K12	Human	M	64 y	Prostate (Pst)	Adenocarcinoma	Malignant	T2aN0M0	2	II		3+3
1	K13	Human	M	58 y	Prostate (Pst)	Adenocarcinoma	Malignant	T2N0M0	2-3	II		3+3
1	K14	Human	M	62 y	Prostate (Pst)	Adenocarcinoma	Malignant	T3N1M1b	2-3	IV		3+4
1	K15	Human	M	82 y	Prostate (Pst)	Adenocarcinoma	Malignant	T2N0M0	3	II		4+5
1	K16	Human	M	40 y	Prostate (Pst)	Adenocarcinoma	Malignant	T2N1M1b	3	IV		4+4
1	L1	Human	M	70 y	Testis (Tes)	Seminoma	Tumor	T1N0M0		I
1	L2	Human	M	30 y	Testis (Tes)	Seminoma	Tumor	T1N0M0		I
1	L3	Human	M	32 y	Testis (Tes)	Seminoma	Tumor	T1N0M0		I
1	L4	Human	M	35 y	Testis (Tes)	Seminoma	Tumor	T4N0M0		I
1	L5	Human	M	42 y	Testis (Tes)	Seminoma	Tumor	T2N0M0		I
1	L6	Human	M	38 y	Testis (Tes)	Seminoma	Tumor	T1N0M0		I
1	L7	Human	M	44 y	Testis (Tes)	Seminoma	Tumor	T1N0M0		I
1	L8	Human	M	34 y	Testis (Tes)	Seminoma	Tumor	T1N0M0		I
1	L9	Human	M	59 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	1	I
1	L10	Human	M	70 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	1	I
1	L11	Human	M	76 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T4N0M0		IV
1	L12	Human	F	57 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	2	I
1	L13	Human	M	46 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	1	I
1	L14	Human	M	54 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	1	I
1	L15	Human	M	76 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	2	I
1	L16	Human	M	40 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T1N0M0	1	I
1	M1	Human	M	55 y	Kidney (Kid)	Granular cell tumor	Tumor	T2N0M0	2	II
1	M2	Human	M	71 y	Kidney (Kid)	Granular cell tumor	Tumor	T1N0M0	2	I
1	M3	Human	F	42 y	Kidney (Kid)	Granular cell tumor	Tumor	T2N0M0	2	II
1	M4	Human	M	41 y	Kidney (Kid)	Granular cell tumor	Tumor	T2N0M0	2	II
1	M5	Human	M	83 y	Kidney (Kid)	Granular cell tumor	Tumor	T2N0M0	3	II
1	M6	Human	M	49 y	Kidney (Kid)	Granular cell tumor	Tumor	T2N0M0	3	II
1	M7	Human	M	77 y	Kidney (Kid)	Granular cell tumor	Tumor	T1N0M0	2	I
1	M8	Human	M	63 y	Kidney (Kid)	Granular cell tumor	Tumor	T2N0M0	1	II
1	M9	Human	M	48 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2	I
1	M10	Human	M	45 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3bN0M0	2	III
1	M11	Human	M	67 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2	I
1	M12	Human	M	55 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3bN0M0	2	III
1	M13	Human	F	36 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	1-2	II
1	M14	Human	M	74 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	2	II
1	M15	Human	M	50 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3bN0M0	2	III
1	M16	Human	M		Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	3	I
1	N1	Human	U		Skin (Skn)	Malignant melanoma	Malignant

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.